These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31999726)

  • 1. Abnormal LAMP1 glycosylation may play a role in Niemann-Pick disease, type C pathology.
    Cawley NX; Sojka C; Cougnoux A; Lyons AT; Nicoli ER; Wassif CA; Porter FD
    PLoS One; 2020; 15(1):e0227829. PubMed ID: 31999726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex N-Linked Glycosylation: A Potential Modifier of Niemann-Pick Disease, Type C1 Pathology.
    Cawley NX; Lyons AT; Abebe D; Luke R; Yerger J; Telese R; Wassif CA; Bailey-Wilson JE; Porter FD
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Novel Pathways Associated with Patterned Cerebellar Purkinje Neuron Degeneration in Niemann-Pick Disease, Type C1.
    Martin KB; Williams IM; Cluzeau CV; Cougnoux A; Dale RK; Iben JR; Cawley NX; Wassif CA; Porter FD
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906248
    [No Abstract]   [Full Text] [Related]  

  • 4. Geranylgeranyl pyrophosphate is crucial for neuronal survival but has no special role in Purkinje cell degeneration in Niemann Pick type C1 disease.
    Marschalek N; Albert F; Afshordel S; Meske V; Eckert GP; Ohm TG
    J Neurochem; 2015 Apr; 133(1):153-61. PubMed ID: 25319340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased interactions and engulfment of dendrites by microglia precede Purkinje cell degeneration in a mouse model of Niemann Pick Type-C.
    Kavetsky L; Green KK; Boyle BR; Yousufzai FAK; Padron ZM; Melli SE; Kuhnel VL; Jackson HM; Blanco RE; Howell GR; Soto I
    Sci Rep; 2019 Oct; 9(1):14722. PubMed ID: 31605022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxypropyl-beta and -gamma cyclodextrins rescue cholesterol accumulation in Niemann-Pick C1 mutant cell via lysosome-associated membrane protein 1.
    Singhal A; Szente L; Hildreth JEK; Song B
    Cell Death Dis; 2018 Oct; 9(10):1019. PubMed ID: 30282967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single Cell Transcriptome Analysis of Niemann-Pick Disease, Type C1 Cerebella.
    Cougnoux A; Yerger JC; Fellmeth M; Serra-Vinardell J; Martin K; Navid F; Iben J; Wassif CA; Cawley NX; Porter FD
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32731618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural history of cerebellar degeneration of Niemann-Pick C mice monitored in vitro.
    Marschalek N; Albert F; Meske V; Ohm TG
    Neuropathol Appl Neurobiol; 2014 Dec; 40(7):933-45. PubMed ID: 24889722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracerebroventricular Treatment with 2-Hydroxypropyl-β-Cyclodextrin Decreased Cerebellar and Hepatic Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Expression in Niemann-Pick Disease Type C Model Mice.
    Fukaura M; Ishitsuka Y; Shirakawa S; Ushihama N; Yamada Y; Kondo Y; Takeo T; Nakagata N; Motoyama K; Higashi T; Arima H; Kurauchi Y; Seki T; Katsuki H; Higaki K; Matsuo M; Irie T
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial.
    Ory DS; Ottinger EA; Farhat NY; King KA; Jiang X; Weissfeld L; Berry-Kravis E; Davidson CD; Bianconi S; Keener LA; Rao R; Soldatos A; Sidhu R; Walters KA; Xu X; Thurm A; Solomon B; Pavan WJ; Machielse BN; Kao M; Silber SA; McKew JC; Brewer CC; Vite CH; Walkley SU; Austin CP; Porter FD
    Lancet; 2017 Oct; 390(10104):1758-1768. PubMed ID: 28803710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and pharmacological evidence implicates cathepsins in Niemann-Pick C cerebellar degeneration.
    Chung C; Puthanveetil P; Ory DS; Lieberman AP
    Hum Mol Genet; 2016 Apr; 25(7):1434-46. PubMed ID: 26908626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered levels and distribution of amyloid precursor protein and its processing enzymes in Niemann-Pick type C1-deficient mouse brains.
    Kodam A; Maulik M; Peake K; Amritraj A; Vetrivel KS; Thinakaran G; Vance JE; Kar S
    Glia; 2010 Aug; 58(11):1267-81. PubMed ID: 20607864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC3 Immunostaining in the Inferior Olivary Nuclei of Cats With Niemann-Pick Disease Type C1 Is Associated With Patterned Purkinje Cell Loss.
    Gurda BL; Bagel JH; Fisher SJ; Schultz ML; Lieberman AP; Hand P; Vite CH; Swain GP
    J Neuropathol Exp Neurol; 2018 Mar; 77(3):229-245. PubMed ID: 29346563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tonic prime-boost of STING signalling mediates Niemann-Pick disease type C.
    Chu TT; Tu X; Yang K; Wu J; Repa JJ; Yan N
    Nature; 2021 Aug; 596(7873):570-575. PubMed ID: 34290407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Potential Role of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Niemann-Pick Disease, Type C1.
    Cawley NX; Lyons AT; Abebe D; Wassif CA; Porter FD
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental delay in motor skill acquisition in Niemann-Pick C1 mice reveals abnormal cerebellar morphogenesis.
    Caporali P; Bruno F; Palladino G; Dragotto J; Petrosini L; Mangia F; Erickson RP; Canterini S; Fiorenza MT
    Acta Neuropathol Commun; 2016 Sep; 4(1):94. PubMed ID: 27586038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Niemann-Pick C1 mouse models, glial-only expression of the normal gene extends survival much further than do changes in genetic background or treatment with hydroxypropyl-beta-cyclodextrin.
    Marshall CA; Watkins-Chow DE; Palladino G; Deutsch G; Chandran K; Pavan WJ; Erickson RP
    Gene; 2018 Feb; 643():117-123. PubMed ID: 29223359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necroptosis inhibition as a therapy for Niemann-Pick disease, type C1: Inhibition of RIP kinases and combination therapy with 2-hydroxypropyl-β-cyclodextrin.
    Cougnoux A; Clifford S; Salman A; Ng SL; Bertin J; Porter FD
    Mol Genet Metab; 2018 Dec; 125(4):345-350. PubMed ID: 30392741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic AAV9 gene therapy improves the lifespan of mice with Niemann-Pick disease, type C1.
    Chandler RJ; Williams IM; Gibson AL; Davidson CD; Incao AA; Hubbard BT; Porter FD; Pavan WJ; Venditti CP
    Hum Mol Genet; 2017 Jan; 26(1):52-64. PubMed ID: 27798114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imatinib therapy blocks cerebellar apoptosis and improves neurological symptoms in a mouse model of Niemann-Pick type C disease.
    Alvarez AR; Klein A; Castro J; Cancino GI; Amigo J; Mosqueira M; Vargas LM; Yévenes LF; Bronfman FC; Zanlungo S
    FASEB J; 2008 Oct; 22(10):3617-27. PubMed ID: 18591368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.